南アフリカのジェネリック医薬品産業プロファイルでは、市場規模（2018〜2023年の値、および2028年までの予測）などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Aspen Pharmacare Holdings Ltd
8.2. Adcock Ingram Holdings Ltd
8.3. Teva Pharmaceutical Industries Ltd
8.4. Cipla Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: South Africa generics market value: $ million, 2018-23
Table 2: South Africa generics market volume: % of total pharma volume, 2018-23
Table 3: South Africa generics market geography segmentation: $ million, 2023
Table 4: South Africa generics market value forecast: $ million, 2023-28
Table 5: South Africa generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Aspen Pharmacare Holdings Ltd: Key Facts
Table 7: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 8: Aspen Pharmacare Holdings Ltd: Key Employees
Table 9: Adcock Ingram Holdings Ltd: Key Facts
Table 10: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 11: Adcock Ingram Holdings Ltd: Key Employees
Table 12: Teva Pharmaceutical Industries Ltd: Key Facts
Table 13: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 14: Teva Pharmaceutical Industries Ltd: Key Employees
Table 15: Cipla Ltd: Key Facts
Table 16: Cipla Ltd: Annual Financial Ratios
Table 17: Cipla Ltd: Key Employees
Table 18: South Africa Size of Population (million), 2019-23
Table 19: South AfricaReal GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 20: South Africa GDP (Current Prices, $ Billion), 2019-23
Table 21: South Africa Inflation, 2019-23
Table 22: South Africa Consumer Price Index (Absolute), 2019-23
Table 23: South Africa Exchange Rate, 2018-23
List of Figures
Figure 1: South Africa generics market value: $ million, 2018-23
Figure 2: South Africa generics market volume: % of total pharma volume, 2018-23
Figure 3: South Africa generics market geography segmentation: % share, by value, 2023
Figure 4: South Africa generics market value forecast: $ million, 2023-28
Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in South Africa, 2023
Figure 7: Drivers of buyer power in the generics market in South Africa, 2023
Figure 8: Drivers of supplier power in the generics market in South Africa, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2023
Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2023
